ProMIS Neurosciences is trading at $4.05, up 10.96% in live trading on November 6, 2026, while the cause of the gain remains unclear. - The company’s latest listed announcement, dated November 5, concerned upcoming conference appearances and does not establish a reason for the November 6 move. - Supplied sector context shows biotech weakness, which does not explain the stock’s gain.